Noe DA[au] - Search Results

Year	Number of Results
1981	1
1982	1
1983	2
1984	2
1985	2
1986	4
1987	2
1988	2
1989	5
1990	2
1991	3
1992	2
1993	4
1994	2
1995	2
1996	3
1997	2
1998	1
2001	2
2003	2
2004	2
2005	1
2006	1
2007	1
2009	1
2010	2
2011	2
2012	3
2014	2
2016	1
2017	1
2019	2
2020	4
2021	0

1

Parameter Estimation and Reporting in Noncompartmental Analysis of Clinical Pharmacokinetic Data.

Noe DA. Noe DA. Clin Pharmacol Drug Dev. 2020 Jul;9 Suppl 1:S5-S35. doi: 10.1002/cpdd.810. Clin Pharmacol Drug Dev. 2020. PMID: 32706165

2

Rejoinder to comments from D. Weiner and N.S. Teuscher on: Performance characteristics of the adjusted r² algorithm for determining the start of the terminal disposition phase and comparison with a simple r² algorithm and a visual inspection method https://onlinelibrary.wiley.com/doi/10.1002/pst.1979 and Criteria for reporting noncompartmental estimates of half-life and area under the curve extrapolated to infinity https://onlinelibrary.wiley.com/doi/10.1002/pst.1978.

Noe DA. Noe DA. Pharm Stat. 2020 Mar;19(2):115-116. doi: 10.1002/pst.2001. Epub 2020 Jan 10. Pharm Stat. 2020. PMID: 31925872 Review. No abstract available.

3

Criteria for reporting noncompartmental estimates of half-life and area under the curve extrapolated to infinity.

Noe DA. Noe DA. Pharm Stat. 2020 Mar;19(2):101-112. doi: 10.1002/pst.1978. Epub 2019 Nov 6. Pharm Stat. 2020. PMID: 31692245

4

Performance characteristics of the adjusted r² algorithm for determining the start of the terminal disposition phase and comparison with a simple r² algorithm and a visual inspection method.

Noe DA. Noe DA. Pharm Stat. 2020 Mar;19(2):88-100. doi: 10.1002/pst.1979. Epub 2019 Oct 29. Pharm Stat. 2020. PMID: 31660697

5

Some Methodologic Considerations in the Assessment of Methods for Predicting Pharmacokinetic Drug-Drug Interactions.

Noe DA. Noe DA. Clin Pharmacol Drug Dev. 2017 Nov;6(6):529-533. doi: 10.1002/cpdd.373. Epub 2017 Jul 24. Clin Pharmacol Drug Dev. 2017. PMID: 28741311 No abstract available.

6

A mathematical model of coagulation factor VIII kinetics.

Noe DA. Noe DA. Haemostasis. 1996 Nov-Dec;26(6):289-303. doi: 10.1159/000217222. Haemostasis. 1996. PMID: 8979143 Review.

7

Tremelimumab (CP-675,206), a cytotoxic T lymphocyte associated antigen 4 blocking monoclonal antibody in clinical development for patients with cancer.

Ribas A, Hanson DC, Noe DA, Millham R, Guyot DJ, Bernstein SH, Canniff PC, Sharma A, Gomez-Navarro J. Ribas A, et al. Among authors: noe da. Oncologist. 2007 Jul;12(7):873-83. doi: 10.1634/theoncologist.12-7-873. Oncologist. 2007. PMID: 17673618 Free article. Review.

8

Measuring flexion in knee arthroplasty patients.

Edwards JZ, Greene KA, Davis RS, Kovacik MW, Noe DA, Askew MJ. Edwards JZ, et al. Among authors: noe da. J Arthroplasty. 2004 Apr;19(3):369-72. doi: 10.1016/j.arth.2003.12.001. J Arthroplasty. 2004. PMID: 15067653

9

Male prairie voles with different avpr1a microsatellite lengths do not differ in courtship behaviour.

Graham BM, Solomon NG, Noe DA, Keane B. Graham BM, et al. Among authors: noe da. Behav Processes. 2016 Jul;128:53-7. doi: 10.1016/j.beproc.2016.04.006. Epub 2016 Apr 12. Behav Processes. 2016. PMID: 27083501

10

Neonatal hypocalcemia and related conditions.

Noe DA. Noe DA. Clin Lab Med. 1981 Jun;1(2):227-38. Clin Lab Med. 1981. PMID: 7049516 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results